Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Abramson Cancer Center at Penn Medicine
Sanofi
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
University of California, San Diego
South Plains Oncology Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Albert Einstein College of Medicine
Children's Mercy Hospital Kansas City
St. Jude Children's Research Hospital
Therapeutic Advances in Childhood Leukemia Consortium
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
Texas Oncology Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
St. Jude Children's Research Hospital